Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 20, 2007

View Archived Issues

Vinorelbine-cisplatin confirmed superior in stage II-IIIA NSCLC / News in Context

Eisai: Q3 report

Recent patents report new therapeutic agents for metabolic disorders

Recent Nissan Chemical patents describe new treatment options for thrombocytopenia

Axcan updates Q1 developments

ZymoGenetics' rhThrombin BLA accepted for review

SGX reviews oncology pipeline

Ark Therapeutics discusses phase III Vitor study with regulatory agencies

Valeant acquires rights to nabilone in the U.K. and Europe

KeyNeurotek and Max-Planck sign licensing agreement

Merck begins registrations of Atripla in developing countries

Inspire to commercialize AzaSite in U.S. and Canada

Gestiva reduces cervical shortening

Canarypox HIV vaccine responses in phase II not sufficient for phase III investigation

Pipex Pharmaceuticals' Coprexa awarded NIH grant for Alzheimer's disease

Post hoc subgroup analysis for Chrysalin in fracture repair

Safety, absorption of TMC-120 assessed in women with and without HIV

Traditional Chinese preparation to enter the clinic for the treatment of allergic asthma

New agents for treating neurological disorders disclosed in recent patents

Recent patents disclose novel treatments for diabetes

Cadherin-11: a potential target against rheumatoid arthritis

Cognitive and mood improvement after guarana therapy reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...